Skip to main content

Advertisement

Log in

Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Raynaud’s phenomenon (RP) is frequent in autoimmune connective tissue diseases (AICTD) and its approach includes nailfold capillaroscopy (NFC), as it is a non-invasive technique that permits direct visualization of the microcirculation. The aim of this study is to analyze and establish clinical correlations between NFC findings and particular aspects of autoimmune disorders. This is a retrospective study. Clinical data from patients attending our NFC clinic were reviewed. Inclusion criteria included AICTD previous diagnosis, which included systemic sclerosis (SSc), mixed connective tissue disease (MCTD), systemic lupus erythematosus (SLE), Sjögren syndrome, inflammatory idiopathic myopathies (IIM), rheumatoid arthritis, undifferentiated connective tissue disease and antiphospholipid syndrome (APS). Videocap® version 3.0 biomicroscope was used. NFC score was determined. For statistics, SPSS software was utilized. 384 patients were included; most of them were women, with mean age of 47 years. RP was present in 91% of the patients, with greater prevalence in SSc and MCTD. Scleroderma pattern was the most prevalent NFC pattern, mainly in SSc, MCTD and IIM. Mean capillary density was reduced in IIM, SSc and MCTD. NFC score was worse in SSc, IIM and MCTD. In patients with AICTD, RP is related to microvascular damage and worse NFC score. NFC scleroderma pattern correlates with SSc classification criteria score. In MCTD, scleroderma pattern relates to myositis. SLE and APS reveal significant hemorrhages, but not related to APS antibodies. This study highlights the possible role of NFC as biomarker of AICTD, particularly in SSc and IIM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Silman A, Holligan S, Brennan P et al (1990) Prevalence of symptoms of Raynaud’s phenomenon in general practice. BMJ 301(6752):590e2

    Google Scholar 

  2. Smith V, Thevissen K, Trombetta AC et al (2016) Nailfold capillaroscopy and clinical applications in systemic sclerosis. Microcirculation 23:364–372

    PubMed  Google Scholar 

  3. Cutolo M, Sulli A, Pizzorni C et al (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160

    CAS  PubMed  Google Scholar 

  4. Cutolo M, Sulli A, Smith V (2013) How to perform and interpret capillaroscopy. Best Pract Clin Rheumatol 27:237–248

    Google Scholar 

  5. Cutolo M, Melsens K, Wijnant S et al (2018) Nailfold capillaroscopy in systemic lupus erythematosus: a systematic review and critical appraisal. Autoimmun Rev 17:844–852

    Google Scholar 

  6. Sebastiani M, Manfredi A, Vukatana G et al (2012) Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicenter validation study. Ann Rheum Dis 71(1):67–70

    CAS  PubMed  Google Scholar 

  7. van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/european league against rheumatism collaborative iniciative. Ann Rheum 72:1747–1755

    Google Scholar 

  8. Hochberg MC (1997) Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725

    CAS  PubMed  Google Scholar 

  9. Alarcon-Segovia D, Villareal M (1987) Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue disease and anti-nuclear antibodies. Excerpta Medica, Amsterdam, pp 33–40

    Google Scholar 

  10. Amigues JM, Cantagrel A, Abbal M et al (1996) Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol 23(12):2055–2062

    CAS  PubMed  Google Scholar 

  11. Aletaha D, Neogi T, Silman AJ et al (2010) Rheumatoid arthritis classification criteria: an American college of rheumatology/european league against rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588

    PubMed  Google Scholar 

  12. Shiboski CH, Shiboski SC, Seror R et al (2017) 2016 American college of rheumatology/european league against rheumatism classification criteria for primary sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76(1):9–16

    PubMed  Google Scholar 

  13. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306

    CAS  PubMed  Google Scholar 

  14. Mosca M, Neri R, Bombardieri S (1999) Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 17:615–620

    CAS  PubMed  Google Scholar 

  15. Lundberg I, Tjärnlund A, Bottai M et al (2017) 2017 European league against rheumatism/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol 69(12):2271–2282

    PubMed  PubMed Central  Google Scholar 

  16. Cutolo M (2010) Atlas of capillaroscopy in rheumatic diseases. Elsevier, Milano. https://doi.org/10.1155/2011/976427

    Book  Google Scholar 

  17. Cutolo M, Pizzorni C, Tuccio M et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43:719–726

    CAS  PubMed  Google Scholar 

  18. Kabasakal Y, Elvins D, Ring E et al (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Belch J, Carlizza A, Carpentier PH et al (2017) ESVM guidelines—the diagnosis and management of Raynaud’s phenomenon. VASA 46(6):413–423

    PubMed  Google Scholar 

  20. Meier FM, Frommer KW, Dinser R et al (2012) Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 71(8):1355–1360

    PubMed  Google Scholar 

  21. Tani C, Carli L, Vagnani S et al (2014) The diagnosis and classification of mixed connective tissue disease. J Autoimmun 48–49:46–49

    PubMed  Google Scholar 

  22. Sharp GC (1987) Diagnostic criteria for classification of MCTD. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue diseases and anti-nuclear antibodies. Elsevier, Amsterdam, pp 23–32

    Google Scholar 

  23. Kasukawa R et al (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue diseases and anti-nuclear antibodies. Elsevier, Amsterdam, pp 41–47

    Google Scholar 

  24. Alarcon-Segovia D, Cardiel MH (1987) Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharps GC (eds) Mixed connective tissue diseases and anti-nuclear antibodies. Elsevier, Amsterdam, pp 33–40

    Google Scholar 

  25. de Holanda MD, Bonfá E, Fuller R et al (2007) Capillaroscopy is a dynamic process in mixed connective tissue disease. Lupus 16(4):254–258

    Google Scholar 

  26. Hoffman IE, Peene I, Meheus L et al (2004) Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 53(9):1155–1158

    Google Scholar 

  27. Pavlov-Dolijanovic S, Damjanov NS, Vujasinovic SNZ et al (2013) Is there a difference in systemic lupus erythematosus with and without Raynaud’s phenomenon? Rheumatol Int 33(4):859–865

    PubMed  Google Scholar 

  28. Vayssairat M, Abuaf N, Baudot N et al (1998) Abnormal IgG cardiolipin antibody titers in patients with Raynaud’s phenomenon and/or related disorders: prevalence and clinical significance. J Am Acad Dermatol 38(4):555–558

    CAS  PubMed  Google Scholar 

  29. Youinou P, Pennec YL, Katsikis P et al (1990) Raynaud’s phenomenon in primary Sjögren’s syndrome. Br J Rheumatol 29(3):205–207

    CAS  PubMed  Google Scholar 

  30. Kraus A, Caballero-Uribe C, Jakez J et al (1992) Raynaud’s Phenomenon in primary Sjögren’s syndrome. Association with other extraglandular manifestations. J Rheumatol 19(10):1572–1574

    CAS  PubMed  Google Scholar 

  31. Tektonidou M, Kaskani E, Skoupoli FN et al (1999) Microvascular abnormalities in Sjögren’s syndrome: nailfold capillaroscopy. Rheumatology 38:826–830

    CAS  PubMed  Google Scholar 

  32. Rigamonti C, Bogdanos DP, Mytilinaiou MG et al (2011) Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. Int J Rheumatol. https://doi.org/10.1155/2011/976427

    Article  PubMed  PubMed Central  Google Scholar 

  33. Dobloug C, Garen T, Bitter H et al (2015) Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Ann Rheum Dis 74(8):1551–1556

    PubMed  Google Scholar 

  34. Katzap E, Barilla-LaBarca ML, Marder G (2011) Antisynthetase syndrome. Curr Rheumatol Rep 13(3):175–181

    CAS  PubMed  Google Scholar 

  35. Manfredi A, Sebastiani M, Cassone G et al (2015) Nailfold capillaroscopic changes in dermatomyositis and polymyositis. Clin Rheumatol 34:279–284

    CAS  PubMed  Google Scholar 

  36. Sebastiani M, Triantafyllias K, Manfredi A et al (2018) FRI0452 Nailfold capillaroscopy in antisynthetase syndrome (NASCAR): results of a multicenter, international study of the american and european network of antisynthetase syndrome (AENEAS). Ann Rheum Dis 77:755–756

    Google Scholar 

  37. Carroll GJ, Withers K, Bayliss CE (1981) The prevalence of Raynaud’s syndrome in rheumatoid arthritis. Ann Rheum Dis 40(6):567–570

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Saraux A, Allain J, Guedes C et al (1996) Raynaud’s phenomenon in rheumatoid arthritis. J Rheumatol 35(8):752–754

    CAS  Google Scholar 

  39. Rajaei A, Dehghan P, Amiri A (2017) Nailfold capillaroscopy in 430 patients with rheumatoid arthritis. Casp J Intern Med 8(4):269–274

    Google Scholar 

  40. Bordy R, Totoson P, Prati C et al (2018) Microvascular endothelial dysfunction in rheumatoid arthritis. Nat Rev Rheumatol 14(7):404–420

    CAS  PubMed  Google Scholar 

  41. Metisons G, Stavropoulos-Kalinoglou A, Sandoo A (2010) Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. Open Cardiovasc Med J 4:89–96

    Google Scholar 

  42. Mosca M, Tavoni A, Neri R et al (1998) Undifferentiated connective tissue disease: the clinical and serological profiles of 91 patients followed at least 1 year. Lupus 7(2):95–100

    CAS  PubMed  Google Scholar 

  43. De Angelis R, Cerioni A, Del Medico P et al (2005) Raynaud’s phenomenon in undifferentiated connective tissue disease (UCTD). Clin Rheumatol 24(2):145–151

    PubMed  Google Scholar 

  44. Pyrpasopoulou A, Triantafyllou A, Anyfanti P et al (2011) Capillaroscopy as a screening test for clinical antiphospholipid syndrome. Eur J Intern Med 22:e158–e159

    PubMed  Google Scholar 

  45. Sulli A, Pizzorni C, Cutolo M (2000) Nailfold videocapillaroscopy abnormalities in patients with antiphospholipid antibodies. J Rheumatol 27:1574–1576

    CAS  PubMed  Google Scholar 

  46. Lehr HÁ (2000) Microcirculatory dysfunction induced by cigarette smoking. Microcirculation 7(6 Pt 1):367–384

    CAS  PubMed  Google Scholar 

Download references

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vera Bernardino.

Ethics declarations

Conflict of interest

Vera Bernardino, Ana Rodrigues, Ana Lladó and António Panarra declare that they do not have any conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bernardino, V., Rodrigues, A., Lladó, A. et al. Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic. Rheumatol Int 40, 295–301 (2020). https://doi.org/10.1007/s00296-019-04427-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-019-04427-0

Keywords

Navigation